168 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
Independent
Directors
Dr. Francesco Bellini
Roberto Bellini
Dr. Youssef L. Bennani
Franklin M. Berger
Dr. Clarissa Desjardins (1)
Pierre Larochelle
Dr … ) Limited (“Mercer”) as its independent compensation consultant to advise on executive and Board compensation matters including: overall compensation
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
independent legal advice, as the failure to comply strictly with the provisions of the Canada Business Corporations Act, as modified by the Interim … continues as an independent Entity, there are risks that the announcement of the Arrangement and the dedication of substantial resources by the Company
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
, or individual who is a current or former independent contractor, consultant, or director, of or to the Company or any Company Subsidiary.
“Company … 1.368-2(g). None of the Parties knows of any fact or circumstance (without conducting independent inquiry or diligence of the other relevant Parties
6-K
EX-99.3
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
the opportunity to obtain independent legal advice and confirms by the execution of this letter agreement that he or she has either done so or waived his … or her right to do so in connection with the entering into of this letter agreement, and that any failure on the undersigned’s part to seek independent
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
and Corporate Governance Committee
Independent Directors
Dr. Francesco Bellini
Roberto Bellini
Dr. Youssef L. Bennani
Franklin M. Berger
Dr. Clarissa … Mercer (Canada) Limited (“Mercer”) as its independent compensation consultant to advise on executive and Board compensation matters including: overall
6-K
EX-99.1
aukni2t
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.2
7l2bfwqzmja e3ld
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
SUPPL
ashqtkw
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
jy4zzzzvt
14 Nov 22
Open Market Sale Agreementsm
5:19pm
F-10
5s77d3d4n0v 6llx
26 Aug 22
Registration of securities (Canada)
4:48pm
F-10
EX-5.1
ccrzn f55
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
EX-99.2
fcdn1lhapy2i
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
SUPPL
aokfr010sh5xefng10x
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
m3h v9ctguti89i
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
o1k2xbiu5ews4
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.2
ds2wea84at6tgbfl1
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
S-8
EX-23.2
2vjt53kqgen
19 Apr 22
Registration of securities for employees
4:14pm
6-K
EX-99.2
aqaq kvl5xby15obt
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
l4b95uys zk
5 Apr 22
Current report (foreign)
4:07pm
40-F
3dfsy97jiiv06k4ok
23 Feb 22
Annual report (Canada)
5:20pm